Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08599 | 32044821 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in inflammatory bowel disease patients. | 2020 | Details |
| A08602 | 32044315 | Gastroenterology | Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08604 | 32044284 | Clin Res Hepatol Gastroenterol | Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity? | 2020 | Details |
| A08606 | 32043636 | FASEB J | REDD1 deficiency protects against nonalcoholic hepatic steatosis induced by high-fat diet. | 2020 | Details |
| A08625 | 32039382 | JHEP Rep | From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options. | 2019 | Details |
| A08633 | 32038642 | Front Immunol | The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity. | 2020 | Details |
| A08640 | 32035613 | Biochem Biophys Res Commun | MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1. | 2020 | Details |
| A08645 | 32033765 | Gastroenterol Clin North Am | Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives. | 2019 | Details |
| A08646 | 32033764 | Gastroenterol Clin North Am | How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis. | 2019 | Details |
| A08647 | 32033763 | Gastroenterol Clin North Am | Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08649 | 32033761 | Gastroenterol Clin North Am | Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis. | 2019 | Details |
| A08652 | 32033758 | Gastroenterol Clin North Am | Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08654 | 32033223 | Nutrients | Beneficial Effects of a Low-dose of Conjugated Linoleic Acid on Body Weight Gain and other Cardiometabolic Risk Factors in Cafeteria Diet-fed Rats. | 2020 | Details |
| A08655 | 32031871 | Am J Physiol Heart Circ Physiol | Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. | 2020 | Details |
| A08661 | 32029456 | Genes Dev | The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism. | 2020 | Details |
| A08662 | 32029233 | Mol Metab | Hepatic ERα accounts for sex differences in the ability to cope with an excess of dietary lipids. | 2019 | Details |
| A08665 | 32028458 | Med Sci Sports Exerc | Exercise Training Rapidly Increases Hepatic Insulin Extraction in NAFLD. | 2020 | Details |
| A08675 | 32025251 | J Med Life | Cellular Interactions in the Human Fatty Liver. | 2020 | Details |
| A08677 | 32025167 | J Clin Exp Hepatol | Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review. | 2019 | Details |
| A08685 | 32022950 | J Eur Acad Dermatol Venereol | The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. | 2020 | Details |
| A08687 | 32021375 | J Inflamm Res | Saturated Fatty Acids in Obesity-Associated Inflammation. | 2020 | Details |
| A08692 | 32020523 | Biol Trace Elem Res | The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial. | 2020 | Details |
| A08693 | 32020371 | Curr Atheroscler Rep | Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis. | 2020 | Details |
| A08696 | 32019793 | mBio | Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08697 | 32019572 | J Med Case Rep | Thrombotic microangiopathy and liver toxicity due to a combination therapy of leflunomide and methotrexate: a case report. | 2020 | Details |
| A08699 | 32019315 | Rev Esp Enferm Dig | Metabolic syndrome, non-alcoholic fatty liver disease and hepatocarcinoma. | 2020 | Details |
| A08701 | 32017891 | Am J Med | Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? | 2020 | Details |
| A08703 | 32017594 | Am J Physiol Endocrinol Metab | Combined effect of canagliflozin and exercise training on high-fat diet-fed mice. | 2020 | Details |
| A08706 | 32017057 | Eur J Clin Invest | Systemic redox imbalance in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A08707 | 32016853 | Pharmacol Rep | New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis. | 2020 | Details |
| A08708 | 32016448 | Mol Med Rep | Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling. | 2020 | Details |
| A08710 | 32015930 | Liver Res | The acidic pathway of bile acid synthesis: Not just an alternative pathway☆. | 2019 | Details |
| A08712 | 32015322 | Cell Death Dis | Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis. | 2020 | Details |
| A08713 | 32014594 | Int J Surg | Impact of sleeve gastrectomy and dietary change on metabolic and hepatic function in an obesity rat model - Experimental research. | 2020 | Details |
| A08725 | 32010935 | Biosci Rep | Letter to the Editor: Comments on "Obesity associated with a novel mitochondrial tRNACys m.5802A>G mutation in a Chinese family". | 2020 | Details |
| A08726 | 32010600 | J Transl Int Med | Role of Hepatokines in Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A08728 | 32009609 | Turk J Gastroenterol | Inborn errors of metabolism in the differential diagnosis of fatty liver disease. | 2020 | Details |
| A08730 | 32008226 | Aging Clin Exp Res | Prognostic value of non-alcoholic fatty liver disease in the elderly patients. | 2020 | Details |
| A08731 | 32008185 | J Endocrinol Invest | Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD. | 2020 | Details |
| A08735 | 32006558 | Metabolism | Complications, morbidity and mortality of nonalcoholic fatty liver disease. | 2020 | Details |
| A08740 | 32005283 | Trials | Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial. | 2020 | Details |
| A08741 | 32004929 | J Nutr Biochem | Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet. | 2020 | Details |
| A08743 | 32003679 | Curr Pharm Des | Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State? | 2020 | Details |
| A08744 | 32003662 | Curr Pharm Des | Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD). | 2020 | Details |
| A08745 | 32003601 | Am J Physiol Gastrointest Liver Physiol | Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH. | 2020 | Details |
| A08746 | 32002742 | Sleep Breath | Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A08747 | 32002713 | Inflammation | Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD. | 2020 | Details |
| A08748 | 32001554 | Gut | Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. | 2020 | Details |
| A08749 | 32001430 | Wiad Lek | Correction of adipocyte secretion disorders in patients with non-alcoholic fatty liver disease with overweight and obesity | 2019 | Details |
| A08751 | 32001301 | Biochim Biophys Acta Mol Basis Dis | Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver. | 2020 | Details |
| A08756 | 31999890 | J Diabetes Investig | Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study. | 2020 | Details |
| A08758 | 31998789 | Biomed Res Int | Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1. | 2020 | Details |
| A08760 | 31998283 | Front Immunol | Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. | 2020 | Details |
| A08763 | 31993314 | Acta Pharm Sin B | Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice. | 2019 | Details |
| A08768 | 31992372 | Br J Nutr | Flaxseed oil in the context of a weight loss programme ameliorates fatty liver grade in patients with non-alcoholic fatty liver disease: a randomised double-blind controlled trial. | 2020 | Details |
| A08771 | 31991181 | Life Sci | Role of hepatic neuropeptide Y-Y1 receptors in a methionine-choline-deficient model of non-alcoholic steatohepatitis. | 2020 | Details |
| A08773 | 31988879 | Pediatr Gastroenterol Hepatol Nutr | Factors associated with Advanced Bone Age in Overweight and Obese Children. | 2020 | Details |
| A08774 | 31988860 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors. | 2022 | Details |
| A08786 | 31984951 | J Vis Exp | Vinyl Chloride and High-Fat Diet as a Model of Environment and Obesity Interaction. | 2020 | Details |
| A08790 | 31982611 | Clin Gastroenterol Hepatol | Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08794 | 31982006 | Wiad Lek | The role of hydrogen sulfide in the progression of chronic obstructive pulmonary disease in patients with non-alcoholic steatohepatitis | 2019 | Details |
| A08796 | 31981593 | Peptides | The new mechanism of Ghrelin/GHSR-1a on autophagy regulation. | 2020 | Details |
| A08801 | 31980690 | Sci Rep | Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. | 2020 | Details |
| A08830 | 31974458 | Sci Rep | Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity. | 2020 | Details |
| A08831 | 31973813 | Biochem Biophys Res Commun | PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice. | 2020 | Details |
| A08840 | 31969650 | Sci Rep | Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects. | 2020 | Details |
| A08842 | 31969089 | Curr Pharm Des | NAFLD at the Interface of the Mother-Infant Dyad. | 2020 | Details |
| A08856 | 31963648 | J Clin Med | Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial. | 2020 | Details |
| A08857 | 31963560 | Mar Drugs | Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats. | 2020 | Details |
| A08860 | 31959914 | Cell Death Differ | Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. | 2020 | Details |
| A08864 | 31958476 | Diabetes Res Clin Pract | Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children. | 2020 | Details |
| A08869 | 31956725 | Contemp Clin Trials Commun | Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study). | 2019 | Details |
| A08871 | 31955626 | Endocr Res | Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice. | 2020 | Details |
| A08874 | 31954687 | Lancet Gastroenterol Hepatol | Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. | 2020 | Details |
| A08879 | 31953865 | Hepatology | Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3. | 2020 | Details |
| A08880 | 31953745 | Obes Surg | Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08882 | 31953338 | Appl Environ Microbiol | Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis. | 2020 | Details |
| A08886 | 31952573 | Adv Clin Chem | Organokines in disease. | 2019 | Details |
| A08891 | 31950772 | Diabetes Metab J | Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. | 2019 | Details |
| A08893 | 31950520 | Hepatology | Nonphagocytic Activation of NOX2 Is Implicated in Progressive Nonalcoholic Steatohepatitis During Aging. | 2020 | Details |
| A08894 | 31949886 | Oxid Med Cell Longev | Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism. | 2019 | Details |
| A08901 | 31947953 | J Clin Med | Randomised Clinical Trial: Calorie Restriction Regimen with Tomato Juice Supplementation Ameliorates Oxidative Stress and Preserves a Proper Immune Surveillance Modulating Mitochondrial Bioenergetics of T-Lymphocytes in Obese Children Affected by Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A08913 | 31941015 | Int J Mol Sci | Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. | 2020 | Details |
| A08919 | 31937803 | Sci Rep | Integrative analysis of blood and gut microbiota data suggests a non-alcoholic fatty liver disease (NAFLD)-related disorder in French SLAdd minipigs. | 2020 | Details |
| A08922 | 31936903 | Cells | A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries. | 2020 | Details |
| A08927 | 31935398 | Eur J Pharmacol | Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases. | 2020 | Details |
| A08928 | 31935149 | Crit Rev Clin Lab Sci | Fructose and hepatic insulin resistance. | 2020 | Details |
| A08930 | 31933238 | Pharmaceut Med | Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. | 2019 | Details |
| A08934 | 31931541 | Z Gastroenterol | A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. | 2020 | Details |
| A08936 | 31930920 | J Med Chem | The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. | 2020 | Details |
| A08945 | 31929840 | Dis Markers | Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals. | 2019 | Details |
| A08950 | 31928239 | Expert Rev Gastroenterol Hepatol | Fatty liver in pregnancy: a narrative review of two distinct conditions. | 2020 | Details |
| A08951 | 31928222 | Am J Physiol Gastrointest Liver Physiol | Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver. | 2020 | Details |
| A08954 | 31926984 | J Ethnopharmacol | Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response. | 2020 | Details |
| A08958 | 31926095 | J Pediatr Endocrinol Metab | Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. | 2020 | Details |
| A08961 | 31924263 | BMC Res Notes | Association of rs780094 polymorphism of glucokinase regulatory protein with non-alcoholic fatty liver disease. | 2020 | Details |
| A08962 | 31923913 | Pediatr Res | Transmembrane 6 superfamily member 2 167K allele improves renal function in children with obesity. | 2020 | Details |
| A08965 | 31922994 | Clin Transl Gastroenterol | A Human REPIN1 Gene Variant: Genetic Risk Factor for the Development of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08967 | 31921938 | Open Forum Infect Dis | Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006-2016. | 2020 | Details |
| A08968 | 31921875 | Front Med (Lausanne) | PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease. | 2019 | Details |